ArticleJournal of thrombosis and thrombolysis2026
Association of factor V leiden and ischemic stroke in young adults: a national inpatient sample analysis.
Article in Journal of thrombosis and thrombolysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between Factor V Leiden (FVL) and ischemic stroke in young adults remains uncertain. We compared the prevalence of FVL coding in ischemic stroke versus non-stroke hospitalizations and examined in-hospital outcomes among young adults with ischemic stroke in the United States.Using the 2016-2022 National Inpatient Sample, we identified hospitalizations for patients aged 18-49 years with a primary diagnosis of ischemic stroke and a secondary diagnosis of FVL. We compared survey-weighted FVL prevalence between stroke and non-stroke hospitalizations. Among stroke hospitalizations, we evaluated discharge disposition, length of stay, and inflation-adjusted costs with survey-weighted regression models adjusted for demographics and comorbidities. Among 67.8 million hospitalizations of adults aged 18-49 years, 297,905 (0.44%) were for ischemic stroke. FVL coding was more frequent in stroke than non-stroke hospitalizations (0.85% vs. 0.25%, p < .001). Among stroke admissions, FVL prevalence increased from 0.81% in 2016 to 0.95% in 2022 (relative increase 18.3%; p for trend = 0.14), while also rising among non-stroke hospitalizations. Stroke hospitalizations with FVL coding involved patients who were younger, more often female and White, and had fewer recorded traditional vascular risk factors. After adjustment, FVL coding was associated with longer length of stay (9.5% increase) and higher hospital costs (11.2% increase); discharge disposition did not differ meaningfully by FVL status. In this large, cross-sectional inpatient sample, FVL was more frequently coded among young adults hospitalized with ischemic stroke than among other hospitalizations and was associated with greater resource use. However, the design, reliance on ICD-10 codes, and likely differential thrombophilia testing limit causal inference and may partially explain the higher FVL prevalence in stroke admissions. These findings highlight the need for prospective, mechanistically focused studies with standardized thrombophilia testing and detailed stroke phenotyping to clarify the contribution of FVL to arterial ischemic stroke and to identify which patients, if any, might benefit from targeted FVL evaluation and tailored prevention strategies.
Indexed as
Identifiers
41525013What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.